Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)

[71] McIntyre TM(2004)Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma J Hum Genet 49 302-307

[72] Stafforini DM(1997)Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patients Biochem Biophys Res Commun 236 772-775

[73] Sheller JR(2001)Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281→Arg mutation Pharmacogenomics 2 163-175

[74] Blackwell TS(2002)PAF acetylhydrolase gene polymorphisms and asthma severity J Hum Genet 47 99-101

[75] Sapirstein A(2000)Evidence for an association between plasma platelet-activating factor acetylhydrolase deficiency and increased risk of childhood atopic asthma Atherosclerosis 150 209-216

[76] Yull FE(2006)Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population J Surg Res 134 36-43

[77] McIntyre TM(2003)A single nucleotide polymorphism in the plasma PAF acetylhydrolase gene and risk of atherosclerosis in Japanese patients with peripheral artery occlusive disease Diabetes Res Clin Pract 59 219-224

[78] Kriska T(1998)Association of plasma PAF acetylhydrolase gene polymorphism with IMT of carotid arteries in Japanese type 2 diabetic patients Metabolism 47 177-181

[79] Marathe GK(2006)Identification of the G994→ T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men Anadolu Kardiyol Derg 6 132-134

[80] Schmidt JC(1997)Association of platelet-activating factor acetylhydrolase gene polymorphism with premature coronary artery disease in Turkish patients Stroke 28 2417-2420

[71] McIntyre TM(2004)Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma J Hum Genet 49 302-307

[72] Stafforini DM(1997)Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patients Biochem Biophys Res Commun 236 772-775

[73] Sheller JR(2001)Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281→Arg mutation Pharmacogenomics 2 163-175

[74] Blackwell TS(2002)PAF acetylhydrolase gene polymorphisms and asthma severity J Hum Genet 47 99-101

[75] Sapirstein A(2000)Evidence for an association between plasma platelet-activating factor acetylhydrolase deficiency and increased risk of childhood atopic asthma Atherosclerosis 150 209-216

[76] Yull FE(2006)Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population J Surg Res 134 36-43

[77] McIntyre TM(2003)A single nucleotide polymorphism in the plasma PAF acetylhydrolase gene and risk of atherosclerosis in Japanese patients with peripheral artery occlusive disease Diabetes Res Clin Pract 59 219-224

[78] Kriska T(1998)Association of plasma PAF acetylhydrolase gene polymorphism with IMT of carotid arteries in Japanese type 2 diabetic patients Metabolism 47 177-181

[79] Marathe GK(2006)Identification of the G994→ T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men Anadolu Kardiyol Derg 6 132-134

[80] Schmidt JC(1997)Association of platelet-activating factor acetylhydrolase gene polymorphism with premature coronary artery disease in Turkish patients Stroke 28 2417-2420